Significance of blood pressure variability in patients with sepsis

doi:10.5847/wjem.j.issn.1920-8642.2014.01.007

Abstract

Abstract:

BACKGROUND: This study was undertaken to observe the characteristics of blood pressure variability (BPV) and sepsis and to investigate changes in blood pressure and its value on the severity of illness in patients with sepsis.
METHODS: Blood parameters, APACHE II score, and 24-hour ambulatory BP were analyzed in 89 patients with sepsis.
RESULTS: In patients with APACHE II score>19, the values of systolic blood pressure (SBPV), diasystolic blood pressure (DBPV), non-dipper percentage, cortisol (COR), lactate (LAC), platelet count (PLT) and glucose (GLU) were significantly higher than in those with APACHE II score ≤19 (P<0.05 ), whereas the values of procalcitonin (PCT), white blood cell (WBC), creatinine (Cr), PaO₂, C-reactive protein (CRP), adrenocorticotropic hormone (ACTH) and tumor necrosis factor α (TNF-α) were not statistically significant (P>0.05). Correlation analysis showed that APACHE II scores correlated significantly with SBPV and DBPV (P<0.01, r=0.732 and P<0.01, r=0.762). SBPV and DBPV were correlated with COR (P=0.018 and r=0.318; P=0.008 and r=0.353 respectively). However, SBPV and DBPV were not correlated with TNF-α, IL-10, and PCT (P>0.05). Logistic regression analysis of SBPV, DBPV, APACHE II score, and LAC was used to predict prognosis in terms of survival and non-survival rates. Receiver operating characteristics curve (ROC) showed that DBPV was a better predictor of survival rate with an AUC value of 0.890. However, AUC of SBPV, APACHE II score, and LAC was 0.746, 0.831 and 0.915, respectively.
CONCLUSIONS: The values of SBPV, DBPV and non-dipper percentage are higher in patients with sepsis. DBPV and SBPV can be used to predict the survival rate of patients with sepsis.

Key words: Sepsis, Systolic blood pressure variability, Diastolic blood pressure variability, APACHE II score, Inflammatory factor

Nishant Raj Pandey, Yu-yao Bian, Song-tao Shou. Significance of blood pressure variability in patients with sepsis[J]. World Journal of Emergency Medicine, 2014, 5(1): 42-47.

Figures/Tables 4

Table 1

Table 2

Table 3

Figure 1.

References 25

1	O'Brien E. Ambulatory blood pressure measurement: a trove of hidden gems? Hypertension 2006; 48:364-365. pmid: 16880346
2	Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, et al. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001; 19:1981-1989. pmid: 11677363
3	Li WY, Wang XH, Lu LC, Li H. Discrepancy of blood pressure between the brachial artery and radial artery. World J Emerg Med 2013; 4:294-297. doi: 10.5847/wjem.j.issn.1920-8642.2013.04.010 pmid: 25215136
4	Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5:93-98.
5	Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007; 50:325-332. Epub 2007 Jun 11.
6	Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871. doi: 10.1001/jama.288.7.862 pmid: 12186604
7	Ren HS, Gao SX, Wang CT, Chu YF, Jiang JJ, Zhang JC, et al. Effects of high-volume hemofiltration on alveolararterial oxygen exchange in patients with refractory septic shock. World J Emerg Med 2011; 2:127-131. pmid: 25214997
8	Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348:727-734. doi: 10.1056/NEJMra020529 pmid: 12594318
9	Briegel J. Hydrocortisone and the reduction of vasopressors in septic shock: therapy or only chart cosmetics? Intensive Care Med 2000; 26:1723-1726. pmid: 11271077
10	No authors listed. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874. pmid: 1597042
11	Xie J, Lu YM, Shi JD, Deng XQ, Long W. Visfatin levels in patients with severe pneumonia. World J Emerg Med 2011; 2:132-136. doi: 10.5847/wjem.j.1920-8642.2011.02.010 pmid: 25214998
12	Papachristou GI, Muddana V, Yadav D, O'Connell M, Sanders MK, Slivka A, et al. Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure,complications, and mortality in acute pancreatitis. Am J Gastroenterol 2010; 105:435-441. doi: 10.1038/ajg.2009.622 pmid: 19861954
13	Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462-1536. Epub 2007 Jun 11. doi: 10.1093/eurheartj/ehm236 pmid: 17562668
14	Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11:1133-1137. doi: 10.1097/00004872-199310000-00019 pmid: 8258679
15	Pierdomenico SD, Di NM, Esposito AL, Di MR, Ballone E, Lapenna D, et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens 2009; 22:842-847.
16	Parati G, Bilo G, Vettorello M, Groppelli A, Maronati A, Tortorici E, et al. Assessment of overall blood pressure variability and its different components. Blood Press Monit 2003; 8:155-159.
17	Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol 2004; 5:575-581. doi: 10.1038/ni1078 pmid: 15164017
18	Wang HX, Chen B. Diagnostic role of soluble triggering receptor expressed on myeloid cell-1 in patients with sepsis. World J Emerg Med 2011; 2:190-194. pmid: 25215008
19	Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1:355-357. pmid: 14246709
20	Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 2005; 23:488-493.
21	Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA, The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009; 15:496-497. doi: 10.1038/nm0509-496 pmid: 19424209
22	Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150. doi: 10.1056/NEJMra021333 pmid: 12519925
23	Joyner MJ, Charkoudian N, Wallin BG. A sympathetic view of the sympathetic nervous system and human blood pressure regulation. Exp Physiol 2008; 93:715-724. pmid: 18326553
24	Charkoudian N, Rabbitts JA. Sympathetic neural mechanisms in human cardiovascular health and disease. Mayo Clin Proc 2009; 84:822-830. doi: 10.1016/S0025-6196(11)60492-8 pmid: 19720780
25	Cowley AW Jr, Liard JF, Guyton AC. Role of the baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ Res 1973; 32:564-576. pmid: 4713198

Variables	APACHE II score≤19	APACHE II score>19	μ/t value	P value
SBPV (mmHg)	35.00 (15.50)	58.00 (17.00)	652.50	0.006
DBPV (mmHg)	33.00 (11.50)	57.00 (20.00)	78.50	0.000
24-h SBP (mmHg)	131.00 (22.09)	147.50 (16.00)	216.50	0.011
24-h DBP (mmHg)	72.50 (17.87)	77.50 (11.62)	315.00	0.410
SBP-day (mmHg)	123.80 (16.91)	144.30 (16.90)	44.00	0.013
DBP-day (mmHg)	73.69 (7.95)	77.64 (10.30)	63.00	0.106
SBP-night (mmHg)	127.10 (16.91)	139.90 (16.15)	55.50	0.085
DBP-night (mmHg)	73.61 (10.01)	73.64 (9.19)	79.00	0.560
24-h PP (mmHg)	58.60 (22.57)	68.35 (6.47)	50.00	0.027
PP-day (mmHg)	58.05 (21.85)	68.70 (7.60)	47.00	0.019
PP-night (mmHg)	60.00 (24.32)	66.95 (12.20)	45.50	0.014
Dipper (%)	21.42	7.14
White blood cell (×10⁹/L)	9.57 (08.50)	12.67 (13.74)	715.00	0.138
Platelet count (×10⁹/L)	122.00 (27.00)	134.00 (109.2)	506.00	0.003
Creatinine (μmol/L)	68.00 (23.50)	68.50 (91.87)	795.00	0.813
PaO₂	83.00 (43.50)	73.50 (45.00)	631.50	0.075
C-reactive protein (μg/L)	3.81 (11.32)	7.67 (14.69)	551.50	0.150
Adrenocorticotropic hormone (ng/L)	29.00 (24.40)	31.00 (24.90)	869.00	0.632
TNF-α (ng/L)	25.77 (03.41)	26.28 (4.76)	196.00	0.924
IL-10 (ng/L)	88.39 (23.27)	83.27 (17.76	3.62	0.260
Glucose (mmol/L)	4.70 (1.30)	8.70 (6.35)	292.50	0.000
Mortality (%)	0	29.54

Variables		APACHE II	Cortisol	Adrenocorticotropic hormone	Tumor necrosis factor-α	IL-10	Platelet count	C-reactive protein
SBPV	r_s	0.732^**	0.318^*	0.127	-0.080	0.156	0.026	0.123
	P	0.000	0.018	0.361	0.682	0.420	0.848	0.410
	n	56	55	54	29	29	55	47
DBPV	r_s	0.762^**	0.353^**	0.163	-0.135	0.219	0.189	0.328^*
	P	0.000	0.008	0.240	0.484	0.254	0.167	0.024
	n	56	55	54	29	29	55	47

Variables	B	S.E.	Wald	df	Significance	Exp (B)
SBPV	0.073	0.029	6.219	1	0.013	1.076
DBPV	0.104	0.036	8.227	1	0.004	1.11
APACHE II	0.225	0.059	14.626	1	0.000	1.252
Cortisol	0.138	0.042	10.757	1	0.001	1.148
Lactate	0.286	0.074	14.868	1	0.000	1.331
Glucose	0.161	0.057	7.893	1	0.005	1.175

[1]	Hui Chen, Yuanhua Lu, Songjie Bai, Yang Li, Tao Wang, Long Cai, Xinyi Yang, Yang Fang, Jianguo Wan, Yaqun Tang, Wenqiang Tao, Meiling Huang, Wei Zhong, Fen Liu, Kejian Qian. Stress-hyperglycemia ratio and glycemic variability predict severity and mortality in sepsis-associated acute respiratory distress syndrome [J]. World Journal of Emergency Medicine, 2026, 17(3): 250-257.
[2]	Yi Yao, Wenjin Li, Dejiang Hong, Ze Chen, Kai Peng, Guangju Zhao. Prediction model for quality of life in sepsis survivors one year after discharge [J]. World Journal of Emergency Medicine, 2026, 17(2): 105-112.
[3]	Zengzheng Ge, Xin Lu, Shiyuan Yu, Mubing Qin, Chao Gong, Qun Xu, Yanxia Gao, Joseph Harold Walline, Huadong Zhu, Yi Li. Diagnostic value of mismatch-negativity and P3a event-related potentials for sepsis-associated encephalopathy in non-sedated patients: a pilot study [J]. World Journal of Emergency Medicine, 2026, 17(2): 172-178.
[4]	Jinlan Ma, Li Peng, Hongming Yu, Jianfeng Xie, Ying Tang, Shenglin Su, Libing Ma, Xiaojun Yang. Single-cell transcriptomics reveals pathogen-specific monocyte heterogeneity and potential biomarkers in gram-positive versus gram-negative bloodstream infections [J]. World Journal of Emergency Medicine, 2026, 17(2): 162-171.
[5]	Xin Lu, Mubing Qin, Zengrui Song, Ying Chen, Huadong Zhu, Yanxia Gao, Yi Li. Normal initial lactate level in sepsis patients: is lactate still useful for prognosis prediction? [J]. World Journal of Emergency Medicine, 2026, 17(1): 57-64.
[6]	Yuhui Pan, Yanyan Ma, Ke Wan, Yizhou Xu, Guoxing Wang, Miaorong Xie. Endothelial cell injury: a crucial link in microcirculatory dysfunction associated with sepsis [J]. World Journal of Emergency Medicine, 2026, 17(1): 28-35.
[7]	Wei Gu, Jie Zhong, Chuanzhu Lyu, Guoqiang Zhang, Miaorong Xie, Yuefeng Ma, Wei Guo. An approach for the emergency diagnosis and treatment of sepsis-associated encephalopathy in elderly individuals: a literature review [J]. World Journal of Emergency Medicine, 2025, 16(5): 415-422.
[8]	Zesheng Wu, Fanghui Chen, Chen Xiao, Xue Zhao, Yuansheng Xu, Jinyan Fang, Yinyan Shao. Long-term cardiovascular outcomes and risk factors in adult sepsis survivors: a systematic review and meta-analysis [J]. World Journal of Emergency Medicine, 2025, 16(5): 423-430.
[9]	Qiaosheng Wang, Qiong Luo, Zhiwei Su, Yan Xu, Liangshan Peng, Yin Wen, Hongke Zeng, Hongguang Ding. Activation of the α7 nicotinic acetylcholine receptor mitigates cognitive deficits in mice with sepsis-associated encephalopathy by inhibiting microglial pyroptosis [J]. World Journal of Emergency Medicine, 2025, 16(5): 438-446.
[10]	Sen Jiang, Xiandong Liu, Tong Liu, Yi Gu, Bo An, Chunxue Wang, Dongyang Zhao, Haitao Zhang, Lunxian Tang. Performance of a novel medical artificial intelligence large language model on supporting decision-making for emergency patients with suspected sepsis [J]. World Journal of Emergency Medicine, 2025, 16(5): 447-455.
[11]	Quan Li, Yun Qu, Jinfang Xue, Hai Kang, Chuanzhu Lyu. Exploring lipid-modifying therapies for sepsis through the modulation of circulating inflammatory cytokines: a Mendelian randomization study [J]. World Journal of Emergency Medicine, 2025, 16(3): 256-261.
[12]	Peili Chen, Yan Ge, Huiqiu Sheng, Wenwu Sun, Jiahui Wang, Li Ma, Enqiang Mao. The role of early changes in routine coagulation tests in predicting the occurrence and prognosis of sepsis [J]. World Journal of Emergency Medicine, 2025, 16(2): 136-143.
[13]	Chunxue Wang, Dianyin Yang, Yuxin Zhu, Qian Yang, Tong Liu, Xiandong Liu, Dongyang Zhao, Xiaowei Bao, Tiancao Dong, Li Shao, Lunxian Tang. Circulating circular RNAs act as potential novel biomarkers for sepsis secondary to pneumonia: a prospective cohort study [J]. World Journal of Emergency Medicine, 2025, 16(2): 144-152.
[14]	Azzah S Alharbi, Raghad Hassan Sanyi, Esam I Azhar. Bacteria and host: what does this mean for sepsis bottleneck? [J]. World Journal of Emergency Medicine, 2025, 16(1): 10-17.
[15]	Chao Gong, Shengyong Xu, Youlong Pan, Shigong Guo, Joseph Harold Walline, Xue Wang, Xin Lu, Shiyuan Yu, Mubing Qin, Huadong Zhu, Yanxia Gao, Yi Li. Effects of probiotic treatment on the prognosis of patients with sepsis: a systematic review [J]. World Journal of Emergency Medicine, 2025, 16(1): 18-27.